Arenaviruses 

  • Author: Sandra G Gompf, MD, FACP, FIDSA; Chief Editor: Burke A Cunha, MD   more...
 
Updated: May 20, 2011
 

Background

Arenaviruses are single-stranded ribonucleic acid (RNA) viruses that cause chronic infections in rodents and zoonotically acquired disease in humans through rodent excreta, especially urine. The genus Arenavirus includes 22 viral species and 9 additional arenaviruses that have been recently discovered, for which taxonomic status remains pending. In 1934, the prototypic arenavirus, lymphocytic choriomeningitis (LCM) virus, was first isolated during serial monkey passage of human material that was obtained from a fatal infection in the first documented epidemic of St. Louis encephalitis, a totally unrelated virus. LCM virus was the first recognized cause of aseptic meningitis in humans.

Other arenaviruses from South America and Africa are classic causes of viral hemorrhagic fever syndrome, whereas others have been identified but not found to cause disease or even infection in humans. Most of these viruses are under continuing study.

Arenaviruses have been divided into 2 groups based on whether the virus is found to infect Old World (ie, Eastern Hemisphere) rodents (family Muridae, subfamily Murinae) or New World (ie, Western Hemisphere) rodents (family Muridae, subfamily Sigmodontinae). The New World arenaviruses are further divided into 3 lineages designated clades: A, B, C. LCM virus is the only arenavirus to exist in both areas but is classified as an Old World virus. The following are the major viruses and the other recognized Arenaviridae listed in relationship to their rodent reservoirs.

LCM virus-Lassa virus ( Old World complex

Lymphocytic choriomeningitis virus

  • Rodent -Mus musculus and Mus domesticus (ie, house mouse) and Mesocricetus auratus (ie, Syrian hamster)
  • Location - Europe, Asia, and the Americas
  • Habitat - Peridomestic, grasslands
  • Season – September to October
  • Human contact - Primarily within households

Lassa virus

  • Rodent -Mastomys genus (ie, multimammate mouse)
  • Location - West Africa
  • Habitat - Savanna, forest clearing
  • Season – January to April
  • Human contact - Primarily within houses

Mopeia virus

  • Rodent -M natalensis
  • Location - Southern Africa
  • Habitat – Savanna
  • Season - Unknown
  • Human contact – Unclear

Mobala virus

  • Rodent -Praomys species (ie, soft-furred rat)
  • Location - Central African Republic
  • Habitat – Savanna
  • Season - Unknown
  • Human contact – Unclear

Ippy virus

  • Rodent -Arvicanthus species (ie, Nile grass rat)
  • Location - Central African Republic
  • Habitat - Grassland, savanna
  • Season - Unknown
  • Human contact – Unclear

Lujo virus

  • Rodent – Unknown
  • Location – Zambia
  • Habitat – Unknown, likely similar to Lassa virus
  • Season – Unknown, likely similar to Lassa virus
  • Human contact – Unclear, likely similar to Lassa virus

Other Old World arenaviruses

  • Merino Walk virus (South Africa)
  • Morogoro (Tanzania)
  • Kodoko (Guinea)
  • Dandenong (Australia)

Tacaribe virus New World  c omplex

Clade A

  • Allpahuayo virus (Peru)
  • Flexal virus (Brazil)
  • Parana virus (Paraguay)
  • Pichinde virus (Colombia)
  • Pirital virus (Venezuela)

Clade B

  • Amapari virus
    • Rodent -Oryzomys goeldii (ie, rice rat), Neacomys guianae (ie, bristly mouse)
    • Location - Brazil
    • Habitat - Tropical forest
    • Human contact – Unclear
  • Cupixi virus (Brazil)
  • Guanarito virus (Venezuelan hemorrhagic fever)
    • Rodent -Zygodontomys brevicauda (ie, cane mouse)
    • Location – Central Venezuela
    • Habitat - Grasslands, brush, peridomestic
    • Season – November to January
    • Human contact - Within houses
  • Junin virus (Argentine hemorrhagic fever)
    • Rodent -Calomys masculinus (ie, corn mouse), Akodon azarae (ie, grass field mouse), Bolomys obscurus (ie, dark field mouse)
    • Location - Argentina
    • Habitat - Grasslands, cultivated fields, and hedgerows
    • Season – February to May
    • Human contact - Occupational in fields
  • Machupo virus (Bolivian hemorrhagic fever)
    • Rodent -Calomys callosus (ie, vesper mouse)
    • Location - Bolivia
    • Habitat - Peridomestic, grasslands
    • Season – April to July
    • Human contact - Primarily within houses
  • Sabia virus (Brazilian hemorrhagic fever)
    • Rodent - Unknown
    • Location - Isolated in Brazil
    • Human contact - Single natural human infection, as well as 2 laboratory infections
  • Tacaribe virus
    • Rodent -Artibeus species (ie, fruit-eating bat)
    • Location - Trinidad
    • Habitat - Tropical forest
    • Human contact - Unclear

Clade C

  • Latino virus (Bolivia, Brazil)
  • Oliveros virus (Argentina)

Other New World arenaviruses of questionable taxonomic status

  • Chapare virus
    • Rodent – Unknown
    • Location – Higher altitudes near Cochabamba Bolivia
    • Habitat – Unclear
    • Human contact – Unclear
  • Tamiami virus
    • Rodent -Sigmodon hispidus (ie, hispid cotton rat)
    • Location - Florida
    • Habitat - Grasslands, marsh
    • Human contact – Unclear
  • Whitewater Arroyo
    • Rodent -Neotoma albigula (ie, white-throated wood rat)
    • Location - California, New Mexico
    • Habitat - Grasslands
    • Human contact - Unclear
  • Bear Canyon (United States)
  • Catarina virus (United States)
  • Pinhal virus (Brazil)
  • Skinner Tank virus (United States)
  • Tonto Creek virus (United States)
  • Big Brushy Tank virus (United States)
Next

Pathophysiology

Viral characterization

Arenaviruses are host plasma membrane-enveloped, spherical-to-pleomorphic particles that range in size from 50-300 nm. The envelope that surrounds the virion contains 2 major glycoprotein components (ie, GP1, GP2) that appear as spikelike or clublike projections with variable spacing along the virus lipid coat.

The Arenaviridae generally have been considered negative-sense RNA viruses that contain 2 subgenomic segments, referred to as L (large) and S (small), composed of 2.4 million bases and 1.3 million bases, respectively. The 5' ends of both the L and S strands contain positive-sense RNA; therefore, the viruses are best considered ambisense. Each of the RNA segments consists of 2 nonoverlapped long open reading frames with opposite polarity. The L segment encodes for the viral RNA-dependent RNA polymerase and for the Z protein important for viral budding and other intracellular functions. The S segment encodes for the nucleocapsid protein (N) and the glycoprotein precursor polypeptide (GPC) that is differentially cleaved and glycosylated to form the spike glycoproteins. The N protein is the most antigenic and thus usually measured in the diagnostic indirect fluorescent antibody (IFA) test.

A distinguishing characteristic of arenaviruses is the presence of internal granular structures 20-25 nm in size. On electron microscopy, these structures appear sandlike. The family name, Arena, is derived from the Latin root (arenosos), meaning sand. These sandlike components are host cell–derived ribosomes, which are incorporated into the virus during budding, but apparently not biologically functional.

Genetic susceptibility

The Human Genome Project (HGP) began in 1989 as an international scientific research project with a primary goal of determining the sequence of chemical base pairs that make up human DNA from both a physical and functional standpoint. The essentially complete genome was published in April 2003, save for the highly repetitive sequences surrounding the centromere and telomere. This database of genes has, when possible, been used to link disease with relevant genes in the human genome. The arenaviruses are no exception.

The DAG1 gene, located at 3p21 for example, encodes for 2 dystroglycan proteins, alpha and beta. Alpha dystroglycan appears to be necessary for infection with viruses of the LCM virus-Lassa complex and some New World arenaviruses (Oliveros and Latino) because null mutants were resistant to infection.

The transferrin receptor gene 1, located at 3q29 is a cell surface glycoprotein transferrin receptor that also appears to enhance susceptibility to infection with those of the Tacaribe virus complex.

Pathogenesis (in humans)

Little data are available regarding the pathogenesis of fatal LCM infection, but marked neuronal infection is seen in human encephalitis. In the case of arenavirus hemorrhagic fevers, pathogenesis likely results from direct viral infection of endothelial cells resulting in vascular dysfunction and shock. Immunopathologic events seem less likely, although as seen in most viral infections, high levels of circulating endogenous interferon-alpha and pro-inflammatory cytokines are present that may prove detrimental rather than beneficial in arenavirus infections.

Previous
Next

Epidemiology

Frequency

United States

The number of cases of LCM virus infection is unclear, but a number of clusters have been reported related to pet hamsters or laboratory animals. Recently, 3 fatal cases of infection with a virus similar to Whitewater Arroyo virus were reported in California.

International

Scattered outbreaks of Lassa fever in western Africa and South American hemorrhagic fever occur, representing local public health problems. Public health officials in nonendemic areas must remain vigilant for these infections because imported cases have been described, presumably due to person-to-person spread.[1]

A nosocomial outbreak of disease involving 5 patients, 4 of whom died, occurred in South Africa from September-October 2008 after the index patient was transferred there from Zambia for medical management. The source of infection was never determined, but a novel arenavirus determined by nucleotide sequencing and phylogenetic analysis, since named Lujo virus, was determined to be the cause.

In December 2003 and January 2004, a small number of hemorrhagic fever cases with classical presentation were reported in rural Bolivia. The virus was isolated from 2 of the patients and was identified as an arenavirus using polymerase chain reaction (PCR). Subsequent genome analysis showed it most closely related to Sabiá virus, but it was distinct enough to be anointed a new species named Chapare virus.

Mortality/Morbidity

Arenaviruses persist in nature by infecting rodents, primarily through a one-virus, one-rodent species relationship. Arenaviruses are transmitted to humans through aerosolization of dried excreta, especially urine that has been deposited in the environment. The distribution of the host dictates the distribution of the virus, but with environmental change due global warming and human factors and with the contemporary ease of international travel, they may occur anywhere in the world.

LCM virus

Infection occurs wherever either of the 2 closely related species of the common house mouse (M musculus, M domesticus) exists. The areas include Europe, the Americas, Australia, and Japan. Human infection is more common in rural areas, where a higher rate of infection exists in mice. Sporadic human LCM virus infections have autumn/winter predominance, when mice are more likely to seek human dwellings for shelter and food. The incubation period varies but most often ranges from 5-10 days, unless presenting with nervous system signs, then exposure likely occurred 2-3 weeks prior. Hamsters also can be infected and are more significant disease vectors in laboratory workers and pet owners.

Lassa virus (ie, Lassa fever)

Lassa fever is endemic to West Africa. Originally found in Nigeria, outbreaks have been reported from Sierra Leone, Liberia, and Guinea. Lassa virus was isolated from rodents of the genus Mastomys, members of which aggressively invade houses. Lassa fever is common in the dry season. This viral agent is noteworthy because of its ability to spread from person to person. This also occurs to some degree with South American viruses.[2, 3, 4] The incubation period varies from 3-16 days, and overall mortality rate is estimated to be 1%. The mortality rate is more than 80% in pregnant women in their third trimester and nearly always results in fetal death. Abortion decreases the risk of death to the mother.

South American viral hemorrhagic fevers

These are diseases of South American countries, including Argentina, Bolivia, and Venezuela, caused by the viruses Junin, Machupo, and Guanarito, respectively. Mortality rate in each is about 15-30%.

For Argentine hemorrhagic fever, the main reservoir rodent is C masculinus. This rodent is found in the cornfields, especially from February through May. Therefore, men harvesting corn are particularly at risk. Infectious aerosols are thought to be the most common mode of transmission, but food contamination and direct contact of abraded fingers with blood or tissue from rodents may occur.

Bolivian hemorrhagic fever is found in the tropical savanna of the Beni region in northeastern Bolivia. The reservoir rodent is C callosus, which travels freely around this area. Bolivian hemorrhagic fever is commonly found from April to July. Transmission is believed to occur through aerosols from infected rodents or, possibly, through food contaminated by rodent urine.

Venezuelan hemorrhagic fever, caused by the Guanarito virus, has the cane mouse Zygodontomys brevicauda as a reservoir. People who have moved to the cleared forest areas for agricultural work are most at risk.

Age

The risk of human acquisition of Arenavirus infection is related to age, race, or sex only to the degree that these variables impact contact with dried rodent urine.

Previous
 
 
Contributor Information and Disclosures
Author

Sandra G Gompf, MD, FACP, FIDSA  Associate Professor of Infectious Diseases and International Medicine, University of South Florida College of Medicine; Chief, Infectious Diseases Section, Director, Occupational Health and Infection Control Programs, James A Haley Veterans Hospital

Sandra G Gompf, MD, FACP, FIDSA is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Coauthor(s)

Kevin M Smith, MD  Fellow in Infectious Disease and International Medicine, University of South Florida College of Medicine

Kevin M Smith, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Ulyee Choe, DO  Fellow, Department of Infectious Diseases, University of South Florida College of Medicine

Ulyee Choe, DO is a member of the following medical societies: American College of Physicians, American Osteopathic Association, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Daniel R Lucey, MD, MPH  Chief, Fellowship Program Director, Department of Internal Medicine, Division of Infectious Diseases, Washington Hospital Center; Professor, Department of Internal Medicine, Uniformed Services University of the Health Sciences

Daniel R Lucey, MD, MPH is a member of the following medical societies: Alpha Omega Alpha and American College of Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: eMedicine Salary Employment

Joseph F John Jr, MD, FACP, FIDSA, FSHEA  Clinical Professor of Medicine, Molecular Genetics and Microbiology, Medical University of South Carolina College of Medicine; Associate Chief of Staff for Education, Ralph H Johnson Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References
  1. Bateman C. Arenavirus deaths--emergency air services tighten up. S Afr Med J. Dec 2008;98(12):910, 912, 914. [Medline].

  2. Whitby LR, Lee AM, Kunz S, Oldstone MB, Boger DL. Characterization of lassa virus cell entry inhibitors: Determination of the active enantiomer by asymmetric synthesis. Bioorg Med Chem Lett. May 3 2009;[Medline].

  3. Fichet-Calvet E, Rogers DJ. Risk maps of lassa Fever in west Africa. PLoS Negl Trop Dis. 2009;3(3):e388. [Medline].

  4. Cosset FL, Marianneau P, Verney G, Gallais F, Tordo N, Pécheur EI, et al. Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol. Apr 2009;83(7):3228-37. [Medline].

  5. Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, et al. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. Jun 2009;82(3):95-102. [Medline].

  6. Banerjee C, Allen LJ, Salazar-Bravo J. Models for an arenavirus infection in a rodent population: consequences of horizontal, vertical and sexual transmission. Math Biosci Eng. Oct 2008;5(4):617-45. [Medline].

  7. Biggar RJ, Woodall JP, Walter PD, Haughie GE. Lymphocytic choriomeningitis outbreak associated with pet hamsters. Fifty-seven cases from New York State. JAMA. May 5 1975;232(5):494-500. [Medline].

  8. Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C, Palacios G, et al. Genetic detection and characterization of lujo virus, a new hemorrhagic Fever-associated arenavirus from southern Africa. PLoS Pathog. May 2009;5(5):e1000455. [Medline].

  9. Buchmeier MJ, et al. Arenaviridae: the viruses and their replication. In: Knipe DL, and Howley, PM. Field's Virology. 4. Philadelphia, PA: Lippencott-Raven; 2007:1791-1828.

  10. Buckley SM, Casals J. Pathobiology of Lassa fever. Int Rev Exp Pathol. 1978;18:97-136. [Medline].

  11. Cao W, Henry MD, Borrow P, et al. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. Dec 11 1998;282(5396):2079-81. [Medline].

  12. Centers for Disease Control and Prevention. Arenavirus infection--Connecticut, 1994. MMWR Morb Mortal Wkly Rep. Sep 2 1994;43(34):635-6. [Medline].

  13. Centers for Disease Control and Prevention. Fatal illnesses associated with a new world arenavirus--California, 1999-2000. MMWR Morb Mortal Wkly Rep. Aug 11 2000;49(31):709-11. [Medline].

  14. Charrel RN, Coutard B, Baronti C, et al. Arenaviruses and hantaviruses: From epidemiology and genomics to antivirals. Antiviral Res. May 2011;90(2):102-14. [Medline].

  15. Cummins D, McCormick JB, Bennett D, et al. Acute sensorineural deafness in Lassa fever. JAMA. Oct 24-31 1990;264(16):2093-6. [Medline].

  16. Delgado S, Erickson BR, Agudo R, et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. Apr 2008;4(4):e1000047. [Medline].

  17. Fischer SA, Graham MB, Kuehnert MJ. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med. 2006;354:2208-11.

  18. Hinman AR, Fraser DW, Douglas RG, et al. Outbreak of lymphocytic choriomeningitis virus infections in medical center personnel. Am J Epidemiol. Feb 1975;101(2):103-10. [Medline].

  19. Holmes GP, McCormick JB, Trock SC. Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. Oct 18 1990;323(16):1120-3. [Medline].

  20. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. Feb 20 1992;355(6362):696-702. [Medline].

  21. Inegbenebor U, Okosun J, Inegbenebor J. Prevention of lassa Fever in Nigeria. Trans R Soc Trop Med Hyg. Jan 2010;104(1):51-4. [Medline].

  22. Jay MT, Glaser C, Fulhorst CF. The arenaviruses. J Am Vet Med Assoc. 2005;227:904-15.

  23. Khan SH, Goba A, Chu M, et al. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res. Apr 2008;78(1):103-15. [Medline].

  24. Kiley MP, Lange JV, Johnson KM. Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. Lancet. Oct 6 1979;2(8145):738. [Medline].

  25. Kunz S, de la Torre JC. Novel antiviral strategies to combat human Arenavirus infections. Curr Mol Med. 2005;5:735-51.

  26. Lan S, McLay Schelde L, Wang J, Kumar N, Ly H, Liang Y. Development of infectious clones for virulent and avirulent Pichinde viruses - a model virus to study arenavirus-induced hemorrhagic fevers. J Virol. Apr 22 2009;[Medline].

  27. Maiztegui JI. Clinical and epidemiological patterns of Argentine haemorrhagic fever. Bull World Health Organ. 1975;52(4-6):567-75. [Medline].

  28. Maiztegui JI, McKee KT Jr, Barrera Oro JG, et al. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J Infect Dis. Feb 1998;177(2):277-83. [Medline].

  29. McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. Jan 2 1986;314(1):20-6. [Medline].

  30. Paweska JT, Sewlall NH, Ksiazek TG, et al. Nosocomial outbreak of novel arenavirus infection, southern Africa. Emerg Infect Dis. Oct 2009;15(10):1598-602. [Medline]. [Full Text].

  31. Peters CJ. Lymphocytic Choriomeningitis Virus, Lassa Virus, and the South American Hemorrhagic Fevers. In: Gerald L. Mandell, John E. Bennett, Raphael Dolin. Principles and Practice of Infectious Diseases. 2. 7. Philadelphia, PA: Churchill Livingstone Elsevier; 2010:2295-2302.

  32. Radoshitzky SR, Abraham J, Spiropoulou CF, et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature. Mar 1 2007;446(7131):92-6. [Medline].

  33. Stinebaugh BJ, Schloeder FX, Johnson KM, et al. Bolivian hemorrhagic fever. A report of four cases. Am J Med. Feb 1966;40(2):217-30. [Medline].

  34. Vanzee BE, Douglas RG, Betts RF, et al. Lymphocytic choriomeningitis in university hospital personnel. Clinical features. Am J Med. Jun 1975;58(6):803-9. [Medline].

  35. Zweighaft RM, Fraser DW, Hattwick MA, et al. Lassa fever: response to an imported case. N Engl J Med. Oct 13 1977;297(15):803-7. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.